BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16739755)

  • 41. Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.
    Karia AM; Balane C; Norman R; Robinson S; Lehnbom E; Durakovic I; Laba TL; Joshi R; Webster R
    Int J Pharm Pract; 2020 Oct; 28(5):441-448. PubMed ID: 32347607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Job satisfaction, work commitment and intention to leave among pharmacists: a cross-sectional study.
    Al-Muallem N; Al-Surimi KM
    BMJ Open; 2019 Sep; 9(9):e024448. PubMed ID: 31558448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacists' counseling on oral contraceptives: A theory informed analysis.
    Amin ME; Chewning B
    Res Social Adm Pharm; 2016; 12(5):669-81. PubMed ID: 26386893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knowledge of and readiness for medication therapy management among community pharmacists in Lebanon.
    Domiati S; Sacre H; Lahoud N; Sili G; Salameh P
    Int J Clin Pharm; 2018 Oct; 40(5):1165-1174. PubMed ID: 29858761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constructs underlying community pharmacy dispensing functions relative to Florida pharmacy technicians.
    Wilson DL; Kimberlin CL; Brushwood DB; Segal R
    J Am Pharm Assoc (2003); 2007; 47(5):588-98. PubMed ID: 17848348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient perspective of medication information desired and barriers to asking pharmacists questions.
    Krueger JL; Hermansen-Kobulnicky CJ
    J Am Pharm Assoc (2003); 2011; 51(4):510-9. PubMed ID: 21752774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How community pharmacists prioritize cognitive pharmaceutical services.
    van de Pol JM; Koster ES; Hövels AM; Bouvy ML
    Res Social Adm Pharm; 2019 Sep; 15(9):1088-1094. PubMed ID: 30429104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
    Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
    J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Qatar pharmacists' understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care.
    El Hajj MS; Al-Saeed HS; Khaja M
    Int J Clin Pharm; 2016 Apr; 38(2):330-43. PubMed ID: 26758716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interpersonal perception: a theory and method for studying pharmacists' and patients' views of pharmaceutical care.
    Assa M; Shepherd EF
    J Am Pharm Assoc (Wash); 2000; 40(1):71-81; quiz 123-5. PubMed ID: 10665252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Work activities of pharmacy teams with drug distribution and clinical responsibilities.
    Guerrero RM; Nickman NA; Bair JN
    Am J Health Syst Pharm; 1995 Mar; 52(6):614-20. PubMed ID: 7606575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engaging pharmacy technicians for advanced clinical support tasks in community pharmacies: A cluster analysis.
    Moya A; Unni E; Montuoro J; Desselle SP
    J Am Pharm Assoc (2003); 2019; 59(4S):S32-S38.e1. PubMed ID: 31104978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leveraging quality improvement principles in comprehensive medication management pharmacy practice: A case example.
    Ekstrand MJ; Kobany JM; Pestka DL
    J Am Pharm Assoc (2003); 2020; 60(3):509-515.e1. PubMed ID: 31866385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing community pharmacists' likelihood to ask medication monitoring questions: A factorial survey.
    Witry MJ; Doucette WR
    Res Social Adm Pharm; 2015; 11(5):639-50. PubMed ID: 25573019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.
    Rupp MT; Warholak TL
    J Am Pharm Assoc (2003); 2008; 48(3):364-70. PubMed ID: 18595821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.